ATE217009T1 - Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen - Google Patents

Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen

Info

Publication number
ATE217009T1
ATE217009T1 AT95201845T AT95201845T ATE217009T1 AT E217009 T1 ATE217009 T1 AT E217009T1 AT 95201845 T AT95201845 T AT 95201845T AT 95201845 T AT95201845 T AT 95201845T AT E217009 T1 ATE217009 T1 AT E217009T1
Authority
AT
Austria
Prior art keywords
difluorolactones
difluoronucleosides
deoxy
producing
stereoselective process
Prior art date
Application number
AT95201845T
Other languages
English (en)
Inventor
Ta-Sen Chou
Perry Clark Heath
Lawrence Edward Patterson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE217009T1 publication Critical patent/ATE217009T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95201845T 1987-08-28 1988-08-22 Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen ATE217009T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9072587A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
ATE217009T1 true ATE217009T1 (de) 2002-05-15

Family

ID=22224017

Family Applications (4)

Application Number Title Priority Date Filing Date
AT95201845T ATE217009T1 (de) 1987-08-28 1988-08-22 Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen
AT88307750T ATE164847T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von zwischenverbindungen verwendbar in der herstellung von 2',2'-difluoronucleosiden
AT95201846T ATE202113T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden
AT94202041T ATE179713T1 (de) 1987-08-28 1988-08-22 Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze

Family Applications After (3)

Application Number Title Priority Date Filing Date
AT88307750T ATE164847T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von zwischenverbindungen verwendbar in der herstellung von 2',2'-difluoronucleosiden
AT95201846T ATE202113T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden
AT94202041T ATE179713T1 (de) 1987-08-28 1988-08-22 Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze

Country Status (11)

Country Link
EP (4) EP0688782B1 (de)
JP (5) JP2738540B2 (de)
KR (1) KR970002659B1 (de)
AT (4) ATE217009T1 (de)
CA (1) CA1324128C (de)
DE (4) DE3856527T2 (de)
ES (4) ES2113845T3 (de)
GR (1) GR3026611T3 (de)
HU (3) HU202249B (de)
IE (1) IE81131B1 (de)
IL (1) IL87517A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012129A1 (en) * 1989-03-20 1990-09-20 Ramakrishnan Nagarajan Recovery of difluoro sugar
US5256797A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
US5252756A (en) * 1992-06-22 1993-10-12 Eli Lilly And Company Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
WO1997021719A1 (en) 1995-12-13 1997-06-19 Eli Lilly And Company α, α-DIFLUORO-β-HYDROXY THIOL ESTERS AND THEIR SYNTHESIS
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 Ｄ-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
US8193354B2 (en) 2005-10-28 2012-06-05 Arch Pharmalabs Limited Process for preparation of Gemcitabine hydrochloride
JP2009519325A (ja) * 2005-12-14 2009-05-14 ドン−エー ファーム．カンパニー リミテッド ２’、２’−ジフルオロヌクレオシドと中間体の製造プロセス
KR100741310B1 (ko) * 2006-08-01 2007-08-01 (주) 유일팜테크 젬시타빈의 합성에 유용한 신규한나프탈렌-2-카르복실레이트 유도체와 그의 제조방법
EP2139884B1 (de) * 2007-03-23 2013-12-04 Dongwoo Syntech Co., Ltd. Verfahren zur herstellung von 2'-desoxy-2',2'-difluorcytidin
AU2009257344B2 (en) * 2008-06-12 2014-03-20 Scinopharm Taiwan, Ltd. Crystalline polymorphs of gemcitabine base
GB0812895D0 (en) 2008-07-15 2008-08-20 Glycom As Crystalline carbohydrate derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ATE92499T1 (de) * 1984-12-04 1993-08-15 Lilly Co Eli Tumorbehandlung bei saeugetieren.
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents

Also Published As

Publication number Publication date
EP0630905A1 (de) 1994-12-28
ES2113845T3 (es) 1998-05-16
JPH1072457A (ja) 1998-03-17
DE3856477D1 (de) 2001-07-19
KR890003794A (ko) 1989-04-18
HU9201768D0 (en) 1992-08-28
EP0306190A3 (de) 1991-11-21
CA1324128C (en) 1993-11-09
KR970002659B1 (ko) 1997-03-07
IE81131B1 (en) 2000-03-22
JP2899577B2 (ja) 1999-06-02
DE3856158T2 (de) 1998-08-20
ES2131152T3 (es) 1999-07-16
DE3856158D1 (de) 1998-05-14
DE3856527T2 (de) 2002-10-31
JPH1081696A (ja) 1998-03-31
DE3856330T2 (de) 1999-09-30
ES2176279T3 (es) 2002-12-01
EP0306190A2 (de) 1989-03-08
EP0688783A1 (de) 1995-12-27
EP0688783B1 (de) 2001-06-13
GR3026611T3 (en) 1998-07-31
IE882608L (en) 1989-02-28
JP2810034B2 (ja) 1998-10-15
JPS6471894A (en) 1989-03-16
JPH1072484A (ja) 1998-03-17
JP2777359B2 (ja) 1998-07-16
JP2899576B2 (ja) 1999-06-02
HU206886B (en) 1993-01-28
EP0688782B1 (de) 2002-05-02
JP2738540B2 (ja) 1998-04-08
IL87517A0 (en) 1989-01-31
EP0306190B1 (de) 1998-04-08
DE3856477T2 (de) 2001-11-08
DE3856330D1 (de) 1999-06-10
HU202249B (en) 1991-02-28
ES2157289T3 (es) 2001-08-16
ATE179713T1 (de) 1999-05-15
HUT47590A (en) 1989-03-28
JPH1072483A (ja) 1998-03-17
EP0630905B1 (de) 1999-05-06
IL87517A (en) 1993-05-13
EP0688782A1 (de) 1995-12-27
ATE202113T1 (de) 2001-06-15
HU906268D0 (en) 1991-03-28
DE3856527D1 (de) 2002-06-06
ATE164847T1 (de) 1998-04-15

Similar Documents

Publication Publication Date Title
ATE217009T1 (de) Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen
DE3882242T2 (de) Fermentationsverfahren zur Herstellung von 2-Keto-L-Gulonsäuren.
DE3883408T2 (de) Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen.
DE3784988T2 (de) Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.
DE3787773D1 (de) Zum Abbau von Glycosaminoglycan fähige Enzymzusammensetzung und Verfahren zur Herstellung dieser Zusammensetzung.
DK165375C (da) Fremgangsmaade til selektivt at foroege andelen af faktor a og/eller b0 eller pa og/eller pb i et antibiotikum a 40926-kompleks
DE3785266T2 (de) Stamm zur massenproduktion von epsilon-poly-l-lysin, methode, um diesen stamm zu gebrauchen, und methode zur herstellung von epsilon-poly-l-lysin.
ATE34176T1 (de) 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung.
ATE89604T1 (de) Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
ATA158484A (de) Verfahren zur herstellung von oralen retardformen des alpha-(2,5-dimethoxy-phenyl)-betaglycinamido|thanols
DE69014747T2 (de) Verfahren zur Herstellung von Kaliumtitanarsenat-Einkristallen.
DE3880072T2 (de) N-phenyl-2,2,6,6-tetrahalogencyclohexanimin und verfahren zur herstellung von derivaten des 2,2,6,6-tetrahalogencyclohexanimins und von derivaten des 2,6-dihalogenanilins.
ATE118551T1 (de) Verfahren zur herstellung von s-2,2-r1,r2-1,3- dioxolan-4-methanol.
DE69225610D1 (de) Verfahren zur herstellung von avermectin und kulturen dafür
DE3583794D1 (de) Verfahren zur herstellung von bestaendigen pharmazeutischen zusammensetzungen von prostaglandin-e-derivaten und/oder ihren 15r-formen.
ATE91507T1 (de) Fermentationsverfahren zur herstellung von 2-keto-l-gulonsaeuren.
ATE58140T1 (de) Verfahren zur herstellung eines lactons.
ATE78256T1 (de) Verfahren zur herstellung von makrolid-derivaten.
ATE50795T1 (de) Verfahren zur bakteriellen herstellung von gluconsaeure.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time